The effects of EDURANT or other medications may be affectedif you take
EDURANT along with any of the following medications. Inform your doctor if you take:
Pregnancy and breastfeeding
If you are pregnant or plan to become pregnant, inform your doctor immediately.
Pregnant women should discuss the use of EDURANT with their doctor.
Mothers infected with HIV should not continue breastfeeding, as there is a possibility that the child may contract HIV through breast milk.
Consult your doctor or pharmacist before using any medication.
Driving and operating machines
Some patients may experience fatigue, dizziness, or drowsiness during EDURANT treatment. Do not drive or operate machines if you feel fatigue, dizziness, or drowsiness while taking EDURANT.
EDURANT contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Correct use instructions for adults and adolescents (12 years to 18 years old)The recommended dose of EDURANT is one tablet once a day.
EDURANTmust be taken with a meal. It is essential to take it with food to achieve the correct concentrations of the active ingredient in your body. A nutritional beverage (although rich in proteins) by itself does not substitute a meal.
There are four situations that require special attention:
Removing the child-resistant cap
The bottle has a child-resistant cap. It can be opened by pushing the cap and turning it in the opposite direction to the clock.
If you take more EDURANT than you should
Inform your doctor or pharmacist immediately. In case of overdose, you may experience headaches, nausea, dizziness, and/or abnormal dreams.
If you forget to take EDURANT
If you realizewithin 12 hours of the usual time for taking EDURANT, take the tablet as soon as possible. The EDURANT tablet must be taken with a meal. Then take the next dose as usual. If you realizeafter 12 hours, do not take that dose and continue with the next ones as usual.
Do not take a double dose to compensate for the missed doses.
If you vomit and less than 4 hours have passed since taking EDURANT, take another tablet with food. If you vomit and more than 4 hours have passed since taking EDURANT, it is not necessary to take another tablet until the next scheduled dose.
Contact your doctor if you have any doubts about what to do if you miss a dose or vomit.
Do not interrupt EDURANT treatment
HIV treatment does not cure HIV infection! Do not interrupt EDURANT treatment without consulting your doctor first. Although you may feel better, do not stop taking EDURANT or other HIV medications. If you do, you may increase the risk of the virus becoming resistant. Consult your doctor first.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all people will experience them.
Very frequent:
Rare:
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the national notification system included in theAppendix V. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the bottle after “CAD”. The expiration date is the last day of the month indicated.
Store in the original bottle to protect it from light.
Medicines should not be disposed of through the drains or in the trash. Ask your pharmacist how to dispose of the containers and medicines that you no longer need. This will help protect the environment.
EDURANT Composition
Appearance of the product and contents of the pack
White to off-white, round, biconvex film-coated tablet, engraved with the inscription “TMC” on one face and “25” on the other.
Child-resistant bottle containing 30 film-coated tablets.
Marketing Authorisation Holder
Janssen-Cilag International NV
Turnhoutseweg 30
B-2340 Beerse
Belgium
Responsible for Manufacturing
Janssen-Cilag SpA
Via C. Janssen
Borgo San Michele
04100 Latina
Italy
For further information about this medicinal product, please consult the representative of the marketing authorisation holder in your country:
België/Belgique/Belgien Janssen-Cilag NV Antwerpseweg 15-17 B-2340 Beerse Tel/Tél: +32 14 64 94 11 | Lietuva UAB "JOHNSON & JOHNSON" Konstitucijos pr. 21C LT-08130 Vilnius Tel: +370 5 278 68 88 |
„??????? & ??????? ????????” ???? ?.?. ??????? 4 ?????? ???? ?????, ?????? 4 ????? 1766 ???.: +359 2 489 94 00 | Luxembourg/Luxemburg Janssen-Cilag NV Antwerpseweg 15-17 B-2340 Beerse Belgique/Belgien Tél/Tel: +32 14 64 94 11 |
Ceská republika Janssen-Cilag s.r.o. Walterovo námestí 329/1 CZ-158 00 Praha 5 - Jinonice Tel: +420 227 012 227 | Magyarország Janssen-Cilag Kft. Nagyenyed u. 8-14 H-Budapest, 1123 Tel.: +36 1 884 2858 |
Danmark Janssen-Cilag A/S Bregnerødvej 133 DK-3460 Birkerød Tlf: +45 45 9482 82 | Malta AM MANGION LTD. Mangion Building, Triq Gdida fi Triq Valletta MT-Hal-Luqa LQA 6000 Tel: +356 2397 6000 |
Deutschland Janssen-Cilag GmbH Johnson & Johnson Platz 1 D-41470 Neuss Tel: +49 2137 955 955 | Nederland Janssen-Cilag B.V. Graaf Engelbertlaan 75 NL-4837 DS Breda Tel: +31 76 711 1111 |
Eesti UAB "JOHNSON & JOHNSON" Eesti filiaal Lõõtsa 2 EE-11415 Tallinn Tel: +372 617 7410 | Norge Janssen-Cilag AS Postboks 144 NO-1325-Lysaker Tlf: +47 24 12 65 00 |
Ελλ?δα Janssen-Cilag Φαρμακευτικ? Α.Ε.Β.Ε. Λεωφ?ρος Ειρ?νης 56 GR-151 21 Πε?κη, Αθ?να Tηλ: +30 210 80 90 000 | Österreich Janssen-Cilag Pharma GmbH Vorgartenstraße 206B A-1020 Wien Tel: +43 1 610 300 |
España Janssen-Cilag, S.A. Paseo de las Doce Estrellas, 5-7 E-28042 Madrid Tel: +34 91 722 81 00 | Polska Janssen-Cilag Polska Sp. z o.o. ul. Ilzecka 24 PL-02-135 Warszawa Tel.: +48 22 237 60 00 |
France Janssen-Cilag 1, rue Camille Desmoulins, TSA 91003 F-92787 Issy Les Moulineaux, Cedex 9 Tél: 0 800 25 50 75 / +33 1 55 00 40 03 | Portugal Janssen-Cilag Farmacêutica, Lda. Lagoas Park, Edificio 9 PT-2740-262 Porto Salvo Tel: +351 214 368 600 |
Hrvatska Johnson & Johnson S.E. d.o.o. Oreškoviceva 6h 10010 Zagreb Tel: +385 1 6610 700 | România Johnson & Johnson România SRL Str. Tipografilor nr. 11-15 Cladirea S-Park, Corp B3-B4, Etaj 3 013714 Bucuresti, ROMÂNIA Tel: +40 21 207 1800 |
Ireland Janssen Sciences Ireland UC Barnahely Ringaskiddy IRL – Co. Cork P43 FA46 Tel: +353 1 800 709 122 | Slovenija Johnson & Johnson d.o.o. Šmartinska cesta 53 SI-1000 Ljubljana Tel: +386 1 401 18 00 |
Ísland Janssen-Cilag AB c/o Vistor hf. Hörgatúni 2 IS-210 Garðabær Sími: +354 535 7000 | Slovenská republika Johnson & Johnson s.r.o. CBC III, Karadžicova 12 SK-821 08 Bratislava Tel: +421 232 408 400 |
Italia Janssen-Cilag SpA Via M.Buonarroti, 23 I-20093 Cologno Monzese MI Tel: +39 02 2510 1 | Suomi/Finland Janssen-Cilag Oy Vaisalantie/Vaisalavägen 2 FI-02130 Espoo/Esbo Puh/Tel: +358 207 531 300 |
Κ?προς Βαρν?βας Χατζηπαναγ?ς Λτδ, Λεωφ?ρος Γι?ννου Κρανιδι?τη 226 Λατσι? CY-2234 Λευκωσ?α Τηλ: +357 22 207 700 | Sverige Janssen-Cilag AB Box 4042 SE-16904 Solna Tel: +46 8 626 50 00 |
Sverige Janssen-Cilag AB Box 4042 SE-16904 Solna Tel: +46 8 626 50 00 | United Kingdom Janssen-Cilag Ltd. 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG - UK Tel: +44 1 494 567 444 |
Last update of this leaflet: {MM/AAAA}.
For more detailed information about this medicinal product, please consult the website of the European Medicines Agency:http://www.ema.europa.eu/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.